| NDC Code | 59676-966-02 |
|---|
| Package Description | 1 VIAL in 1 CARTON (59676-966-02) > 25 mL in 1 VIAL |
|---|
| Product NDC | 59676-966 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Doxorubicin Hydrochloride Liposome |
|---|
| Non-Proprietary Name | Doxorubicin Hydrochloride |
|---|
| Dosage Form | INJECTION, SUSPENSION, LIPOSOMAL |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20170626 |
|---|
| End Marketing Date | 20201031 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA050718 |
|---|
| Manufacturer | Janssen Products, LP |
|---|
| Substance Name | DOXORUBICIN HYDROCHLORIDE |
|---|
| Strength | 2 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [CS],Topoisomerase Inhibitors [MoA] |
|---|